[Biopharmaceutical and pharmacokinetic studies on metamizol-14C (Novalgin 14C) given to rats, dogs and men].
D000328:Adult; D000818:Animals; D001702:Biopharmaceutics; D001711:Biotransformation; D002250:Carbon Radioisotopes; D004285:Dogs; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005243:Feces / Q000032:analysis; D006207:Half-Life; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate; D011720:Pyrazoles / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D051381:Rats; D013451:Sulfonic Acids / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology* / Q000652:urine
D002250:Carbon Radioisotopes; D011720:Pyrazoles; D013451:Sulfonic Acids